Owing to their fast diffusion, reactive oxygen species (ROS) are important tissue signalling components. High levels of ROS are generally considered as deleterious to cells. In vivo experiments in the Drosophila hematopoietic organ now challenge this view by showing that high ROS levels are intrinsically required to prime myeloid-like progenitors to differentiate.
Reactive Oxygen Species (ROS) encompass a variety of diverse chemical products including superoxide anions, hydroxyl radicals and hydrogen peroxides. Some ROS, such as superoxide or hydroxyl radicals are extremely unstable whereas some others, like hydrogen peroxide are diffusible and long-lived. These different radical species can either be generated exogenously or produced intra-cellularly by mitochondria. The control of overall ROS levels is crucial to maintain physiological homeostasis. Indeed, above-physiological levels ROS can lead to cell death, acceleration in ageing and age-related diseases. It can also constitute a stress signal in itself that activates redox-sensitive signalling pathways. At the opposite, lowering ROS can interrupt the physiological role of oxidants in several processes like proliferation and host defence. The fine-tuned balance between ROS production and antioxidant defences is therefore crucial for normal growth and metabolism (Finkel and Holbrook, 2000) .
Response to oxidant injury activates several signalling pathways among which the PI3-AKT and the c-Jun amino-terminal kinase (JNK). In both cases, the Forkhead O (FoxO) transcription factors are main effectors. Recent studies in mice, based on conditional deletion of the three foxO genes, foxO1, foxO3 and foxO4 in the adult hematopoietic system have revealed that FoxO proteins play essential roles in the response to physiologic oxidative stress by preserving quiescence and enhancing survival of hematopoietic stem cell (HSC) in the bone marrow (Tothova et al., 2007) . The authors also noted a marked increase in ROS levels associated with the transition from HSC to myeloid progenitors. The role of ROS in regulating the balance between HSC self-renewal and HSC driving into terminal differentiation remains, however, little understood (Ito et al., 2006; Tothova et al., 2007) .
Over the past 15 years, Drosophila has become a major model system for 'deciphering' innate immune defence mechanisms that operate in the animal kingdom. Recent demonstration that a small group of cells, termed posterior signalling centre (PSC), controls hemocyte (blood cell) homeostasis in the Drosophila larval hematopoietic organ, the lymph gland (LG) has revealed unanticipated parallels with the 'niche' of vertebrate HSC (Krzemien et al., 2007; Mandal et al., 2007) . Hemocytes differentiate in the so-called cortical zone of the LG. Two types of hemocytes differentiate in normal developmental conditions: plasmatocytes which are involved in phagocytosis and functionally equivalent to monocytes and crystal cells which are required for melanization/wound healing. A third type of hemocytes, the lamellocytes, represent a cryptic immune cell fate since it is only produced in response to specific immune challenges. Hemocytes start to differentiate during the last, third instar larval stage from a pool of myeloid-like hematopoietic progenitors residing in the medullary zone of the LG. JAK/STAT signalling is required in these progenitors to maintain their progenitor status (Krzemien et al., 2007) . Owusu-Ansah and Banerjee (2009) have used the Drosophila LG to undertake studying the role of ROS in the control of hematopoiesis. They first observed that the progenitor population contains significantly increased ROS levels in the last larval stage but not at earlier developmental stages, indicating that the accumulation of ROS in the LG is under tight developmental control. This temporal window of ROS accumulation suggested that it could be involved in priming progenitors for differentiation. To investigate this question, the authors further increased the level of ROS in the medullary zone, using targeted RNAi against genes encoding complex I proteins of the mitochondrial electron transport chain. Conversely, they reduced ROS levels by targeting expression of superoxide dismutase in the medullary zone. By monitoring the timing of hemocyte differentiation and 'atypical' differentiation of lamellocytes in these different conditions, they could conclude that high ROS levels in progenitors are intrinsic factors sensitising these progenitors to differentiation in all three hemocyte types. Then, using the same genetic tools, they showed that the JNK signalling pathway functions downstream of ROS in this process. On the basis of the finding that JNK function can be mediated by activation of FoxO and repression of Polycomb activity, OwusuAnsah and Banerjee monitored FoxO activation and Polycomb de-repression in the medullary zone, using lacZ reporters as transcriptional read-outs. They found a tight correlation between FoxO overactivation and Polycomb down-regulation in cells with increased ROS levels. Although sufficient to provoke premature differentiation of the two other types of hemocytes, FoxO overexpression by itself did not activate lamellocyte differentiation. In contrast, repression of Polycomb activity in the LG led to the formation of lamellocytes, independently of ROS signalling, correlating with earlier observations based on genetic disruption of Polycomb genes (Remillieux-Leschelle et al., 2002) . In summary, this first study on the role of ROS in the Drosophila hematopoietic organ established that high ROS levels activate JNK signalling in hematopoietic progenitors. This results in FoxO activation and down-regulation of Polycomb activity which combinatorially induce the differentiation of all three types of Drosophila hemocytes.
Several new questions are raised by these important data, which can now be addressed in vivo, using the LG as an experimental system. On one hand, increased levels of ROS in vertebrates were reported to favour the association of FoxO with b-catenin, a downstream component of the Wnt/Wg signalling pathway and enhance FoxO's role in inhibiting cell cycle progression (Essers et al., 2005) . On the other, very recent data from U. Banerjee's lab indicate that Wg signalling in the LG negatively regulates hemocyte differentiation (Sinenko et al., 2009 ). It will be interesting to determine whether and how ROS signalling and Wg signalling could interact in order to control hemocyte homeostasis. The massive differentiation of lamellocytes observed in conditions of increased levels of ROS in the medullary zone is also puzzling since, in wild-type larvae, lamellocytes do only differentiate in response to immune challenges such as wasp parasitism. It raises the possibility that some ROS could be involved as diffusible signalling molecules in orienting hematopoietic progenitors towards lamellocyte differentiation and/or accelerating their release from the LG. Interestingly, evidence has very recently been reported in zebrafish larvae that a gradient of hydrogen peroxide generated at a wound site signals to leucocytes, thereby inducing their local recruitment (Niethammer et al., 2009) . Whether a similar signalling operates between the site of wasp-egg deposition in a fly larva and the LG is now worth being investigated. The possible longrange and paracrine signalling via ROS will also need to be connected to other signalling pathways that operate in the LG, such as JAK/STAT signalling, to get an integrated view of the control of hematopoiesis in different environmental conditions. Finally, the mechanisms underlying the developmental control of ROS levels in mice and Drosophila myeloid progenitors remain to be identified.
These important new findings with the Drosophila LG as a model organ further highlight the general role of ROS as intrinsic regulators for the differentiation of hematopoietic progenitors. Beyond the conservation of the ROS/JNK/FoxO cascade, it will be very interesting to see which parallels can be made between the priming of hematopoietic progenitors for differentiation in the Drosophila LG and the regulation of ROS levels in vertebrates in the transition from HSC to myeloid progenitors.
